Compass therapeutics to present second quarter financial results and provide business update on august 11, 2025

Boston, aug. 08, 2025 (globe newswire) -- compass therapeutics, inc. (nasdaq: cmpx), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics, will release its financial results for the quarter ended june 30, 2025 and host a webcast and conference call to provide an update on the ongoing tovecimig phase 2/3 study, clinical data for ctx-8371 and preclinical data for ctx-10726, on monday, august 11, 2025, at 8:00 a.m. et.
CMPX Ratings Summary
CMPX Quant Ranking